Literature DB >> 16227647

Effects of standard heparin and low-molecular-weight heparins on the formation of murine osteoclasts in vitro.

Joanna Folwarczna1, Leszek Sliwiński, Waldemar Janiec, Małgorzata Pikul.   

Abstract

Long-term administration of heparin can lead to development of osteoporosis. The aim of the present study was to examine the effects of standard heparin and low-molecular-weight heparins (nadroparin, enoxaparin, parnaparin and dalteparin) on osteoclast formation from neonatal murine bone marrow cells stimulated by 1,25-dihydroxyvitamin D3 in vitro. Standard heparin (0.1-10 IU/ml) and low-molecular-weight heparins (1-100 anti-Xa IU/ml) affected the formation of osteoclasts in two directions. In the rat bone marrow cell cultures, at lower concentrations, the heparins tended to increase the formation of osteoclasts, whereas at the highest concentrations (10 IU/ml and 100 anti-Xa IU/ml, respectively) they tended to decrease the number of osteoclasts. In the mouse bone marrow cell culture, the heparins suppressed the formation of osteoclasts, with the exception of standard heparin at 0.1 IU/ml which intensified the process. Results of the present study indicate species differences in the sensitivity of bone marrow cells to standard heparin and low-molecular-weight heparins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16227647

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  4 in total

1.  Proteoglycans and osteolysis.

Authors:  Marc Baud'Huin; Céline Charrier; Gwenola Bougras; Régis Brion; Frédéric Lezot; Marc Padrines; Dominique Heymann
Journal:  Methods Mol Biol       Date:  2012

2.  Glycosaminoglycan mimetic associated to human mesenchymal stem cell-based scaffolds inhibit ectopic bone formation, but induce angiogenesis in vivo.

Authors:  Guilhem Frescaline; Thibault Bouderlique; Leyya Mansoor; Gilles Carpentier; Brigitte Baroukh; Fernando Sineriz; Marina Trouillas; Jean-Louis Saffar; José Courty; Jean-Jacques Lataillade; Dulce Papy-Garcia; Patricia Albanese
Journal:  Tissue Eng Part A       Date:  2013-07       Impact factor: 3.845

3.  Impaired bone healing by enoxaparin via inhibiting the differentiation of bone marrow mesenchymal stem cells towards osteoblasts.

Authors:  Yan Li; Liang Liu; Shuwei Li; Haiyu Sun; Yonghong Zhang; Zhiqing Duan; Dong Wang
Journal:  J Bone Miner Metab       Date:  2021-09-15       Impact factor: 2.626

4.  The Effect of Low Molecular Weight Heparins on Fracture Healing.

Authors:  Stylianos Kapetanakis; Evangelos Nastoulis; Theano Demesticha; Thespis Demetriou
Journal:  Open Orthop J       Date:  2015-06-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.